Product Program year 2024 Source: CMS Open Payments

GammaTile

Device Kxk

Open in the dashboard

General payments

$1,213,106

2,492 payments

Research payments

$1,422,796

238 payments

Through program year 2024, $1,213,106 in general payments and $1,422,796 in research payments were reported against GammaTile (Kxk).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

8 rows
Year Kind Amount Payments
2024 General $345,559 808
2024 Research $1,414,296 233
2023 General $255,754 724
2022 General $200,262 602
2021 General $254,215 290
2021 Research $8,500 5
2020 General $156,654 64
2019 General $661 4

Breakdown

Who paid General payments · program years 2019–2024
  1. GT Medical Technologies, Inc $1,213,106 2,492 payments
Top recipients General payments · program year 2024
  1. David McCracken Neurological Surgery · Atlanta, GA $87,034 25% · 44 payments
  2. Imran Mohiuddin Radiation Oncology · Orlando, FL $29,647 9% · 29 payments
  3. Daniel Kim Radiation Oncology · Fairfax, VA $19,936 6% · 31 payments
  4. Simon Hanft Neurological Surgery · Valhalla, NY $19,145 6% · 27 payments
  5. Matthew Shepard Neurological Surgery · Pittsburgh, PA $16,366 5% · 18 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2024.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2024
  1. Neurological Surgery $178,075 52% · 82 practitioners
  2. Radiation Oncology Radiology $144,232 42% · 94 practitioners
  3. Nurse Practitioner, Acute Care Nurse Practitioner $7,583 2% · 2 practitioners
  4. Neurology Psychiatry & Neurology $6,960 2% · 8 practitioners
  5. Hematology & Oncology Internal Medicine $2,879 <1% · 7 practitioners

The top 5 of 18 specialties; each share is of general payments naming this product to practitioners with a specialty in 2024. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2024
  1. Georgia $90,871 26% · 7 recipients
  2. Florida $56,512 16% · 14 recipients
  3. Arizona $33,873 10% · 17 recipients
  4. New York $26,587 8% · 17 recipients
  5. California $25,283 7% · 39 recipients

The top 5 of 32 states; each share is of general payments naming this product in 2024 where a state was reported.

The top 25 states, free in the app

2,492 general · 238 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2024

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record